Special Issues

Uro publishes Special Issues to create collections of papers on specific topics, with the aim of building a community of authors and readers to discuss the latest research and develop new ideas and research directions. Special Issues are led by Guest Editors, who are experts on the topic and all Special Issue submissions follow MDPI's standard editorial process. The journal’s Editor-in-Chief and/or designated Editorial Board Member will oversee Guest Editor appointments and Special Issue proposals, checking their content for relevance and ensuring the suitability of the material for the journal. The papers published in a Special Issue will be collected and displayed on a dedicated page of the journal’s website. Further information on MDPI's Special Issue policies and Guest Editor responsibilities can be found here. For any inquiries related to a Special Issue, please contact the Editorial Office.

Search by Title/Keyword
 
Order results
Display
Results per page
New Molecular Insights in Bladder Carcinoma submission deadline 29 Aug 2025 | Viewed by 308 | Submission Open
Keywords: bladder cancer; molecular biomarkers; tumor microenvironment; targeted therapy; precision oncology
Urinary Tract Infection: Current Treatment and Future Options
edited by
submission deadline 1 Oct 2025 | Viewed by 132 | Submission Open
Keywords: urinary tract infections (UTIs); antibiotic resistance; probiotics and alternative therapies; diagnostic advancements; urinary infection management
Prostate Surgery: The Latest Advances and Future Trends
edited by Akhil K. Das and
submission deadline 28 Oct 2025 | Viewed by 113 | Submission Open
Keywords: benign prostatic hyperplasia (BPH); minimally invasive surgical therapies (MIST); laser enucleation (HoLEP; ThuLEP); Aquablation; Rezum; robotic prostatectomy; anatomic enucleation
The Clinical Management of Urologic Oncology submission deadline 31 Dec 2025 | Viewed by 178 | Submission Open
Keywords: prostate cancer; bladder cancer; renal cancer; testicular cancer; robotic surgery; genitourinary cancers; molecular biomarkers; treatment outcomes; quality of life
Back to TopTop